Evidence map›Paper›PMID 41530286›Full record

ArticleNature metabolism2026

Antecedent hypoglycaemia impairs glucagon secretion by enhancing somatostatin-mediated negative feedback control.

Rui Gao, Samuel Acreman, Haiqiang Dou, Jinfang Ma, Caroline Miranda, Ruiling Zhao, Matthew T Dickerson, Andrei Tarasov, Qi Zou, Marta Gironella-Torrent and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rui GaoOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0845-1370
Samuel AcremanOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5117-4447
Haiqiang DouInstitute of Neuroscience and Physiology, Department of Physiology, Metabolic Research Unit, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-1551-4114
Jinfang MaOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Caroline MirandaInstitute of Neuroscience and Physiology, Department of Physiology, Metabolic Research Unit, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ruiling ZhaoDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Matthew T DickersonDepartment of Molecular Physiology and Biophysics, Vanderbilt Universit, Nashville, TN, USA.
Andrei TarasovOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8883-176X
Qi ZouSchool of Control Science and Engineering, Shandong University, Jinan, China.ORCID http://orcid.org/0000-0002-8662-5874
Marta Gironella-TorrentDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-2210-8779
Johan TolöInstitute of Neuroscience and Physiology, Department of Physiology, Metabolic Research Unit, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-9648-4721
Anne ClarkOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Rui GaoSchool of Control Science and Engineering, Shandong University, Jinan, China.
Yang De MarinisOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8081-2142
David A JacobsonDepartment of Molecular Physiology and Biophysics, Vanderbilt Universit, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-1816-5375
Joan Camunas-SolerDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-6148-8132
Tao YangDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0001-6375-3622
Patrik RorsmanOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7578-0767
Quan ZhangOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. quan.zhang@ocdem.ox.ac.uk.ORCID http://orcid.org/0000-0002-3626-4855

Funding

Molecular Mechanisms Regulating Pancreatic Delta Cell Function and DysfunctionR01DK129340 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2022 to 2026
$2.3M
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetesR01DK136768 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2023 to 2026
$2.0M
Calcium Extrusion in the Context of Pancreatic Islet Function and DysfunctionR01DK144192 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2025 to 2026
$1.3M
Leona M. and Harry B. Helmsley Charitable Trust (Helmsley Charitable Trust) G-1912-03553 & G-2305-06047National Natural Science Foundation of China (National Science Foundation of China) 82200887NIDDK NIH HHS R01 DK129340NIDDK NIH HHS R01 DK136768NIDDK NIH HHS R01 DK144192Royal Society IEC\NSFC\170394Vetenskapsrådet (Swedish Research Council) 2021-05109
6 · The paper itself

Abstract

Somatostatin, produced by pancreatic islet δ cells, is a key intra-islet paracrine factor that regulates the secretion of the glucoregulatory hormones insulin and glucagon from β cells and α cells, respectively. Here, we show that glutamate and glucagon released by α cells cooperatively activate neighbouring δ cells through AMPA and glucagon receptors, thereby enabling spatiotemporal feedback control of glucagon secretion. Crucially, prior hypoglycaemia enhances this mechanism by sensitizing δ cells to α cell-derived factors and inducing long-lasting structural and functional changes that facilitate δ cell and α cell paracrine interaction. This culminates in somatostatin hypersecretion that impairs counter-regulatory glucagon release. These hypoglycaemia-driven effects were emulated by chemogenetic activation of α cells or high concentrations of exogenous glucagon but prevented by inhibitors of glucagon receptors or the transcription factor CREB. This plasticity represents a key component of the islet's 'metabolic memory', which, through impaired counter-regulatory glucagon secretion, increases the occurrence of recurrent hypoglycaemia that complicates the management of insulin-dependent diabetes.

Indexed as

Feedback, PhysiologicalGlucagonHypoglycemiaSomatostatinAnimalsGlucagon-Secreting CellsInsulinMiceSomatostatin-Secreting CellsGlucagonInsulinSomatostatin

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.